Rama Vision Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison
Rama Vision Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison
Last Updated on: Nov 01, 2026
Key Highlights
The Latest Trading Price of Rama Vision Ltd is ₹ 174.65 as of 30 Oct 15:30
. The P/E Ratio of Rama Vision Ltd changed from 22.6 on March 2021 to 20.4 on March 2026 . This represents a CAGR of -1.69% over 6 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 37.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Rama Vision Ltd changed from ₹ 7.02 crore on March 2021 to ₹ 120.53 crore on March 2026 . This represents a CAGR of 60.62% over 6 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 2.54 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Rama Vision Ltd for the Jun '26 is ₹ 51.5 crore as compare to the Mar '26 revenue of ₹ 42.44 crore. This represent the growth of 21.35% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Rama Vision Ltd for the Jun '26 is ₹ 3.81 crore as compare to the Mar '26 ebitda of ₹ 2.67 crore. This represent the growth of 42.7% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ -49.86 crore. This represent the decline of -100% The net profit of Rama Vision Ltd changed from ₹ 1.19 crore to ₹ 2.09 crore over 9 quarters. This represents a CAGR of 28.44%
The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00%
The Dividend Payout of Rama Vision Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .
About Rama Vision Ltd
Rama Vision Limited (RVL), a JV Company promoted by Satish Jain(and his Associates) in association with Hiltron (a UP Government undertaking) was established in January, 1989.
The Company is one of the leading importer and distributor of Baby and Mother care products, Skin care products, food products etc. all over India through net-work of dealers and distributors and professionally managed strong sales and marketing team.
The Plant located at Kichha, Uttaranchal with an installed capacity to produce 2 million pieces (per annum) of B & W picture tubes and monochrome computer monitor tubes was commissioned on February 20, 1991.
The Company was declared Sick by BIFR on Feb 28, 2001 through its order and appointed IFCI as the Operating Agency to examine the viability and to formulate suitable Rehabilitation Scheme.
About Welcure Drugs & Pharmaceuticals Ltd
Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc.
WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes.
Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.
FAQs for the comparison of Rama Vision Ltd and Welcure Drugs & Pharmaceuticals Ltd
Which company has a larger market capitalization, Rama Vision Ltd or Welcure Drugs & Pharmaceuticals Ltd?
Market cap of Rama Vision Ltd is 182 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr
What are the key factors driving the stock performance of Rama Vision Ltd and Welcure Drugs & Pharmaceuticals Ltd?
The stock performance of Rama Vision Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Rama Vision Ltd and Welcure Drugs & Pharmaceuticals Ltd?
As of November 1, 2026, the Rama Vision Ltd stock price is INR ₹174.65. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.
How do dividend payouts of Rama Vision Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?
To compare the dividend payouts of Rama Vision Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.